Goldman Sachs assumed coverage of HCA Healthcare (HCA) with a Buy rating and $470 price target The firm sees favorable trends continuing for the hospital sector through 2028, including supportive labor dynamics, tailwinds from previously approved pro-utilization government policies, and the industry showing more effective adaptation to structural changes. However, the sector will face new pressures from implementation of the One Big Beautiful Bill, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- HCA Healthcare price target raised to $465 from $370 at KeyBanc
- HCA Healthcare price target raised to $412 from $375 at Wells Fargo
- Nutex Health appoints Wesley Bamburg as COO
- HCA Healthcare price target raised to $445 from $390 at Barclays
- HCA Healthcare price target raised to $430 from $375 at BofA